Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-18 1:45 pm Purchase | 13D | Xenetic Biosciences Inc. XBIO | CLS Therapeutics LLC | 215,964 14.000% | 17,076 (+8.59%) | View |
2023-09-18 12:21 pm Purchase | 13D | Xenetic Biosciences Inc. XBIO | CLS Therapeutics LLC | 198,888 13.000% | 51,388 (+34.84%) | View |
2023-06-15 5:20 pm Sale | 13D | Xenetic Biosciences Inc. XBIO | CLS Therapeutics LLC | 147,500 9.700% | -1,327,500 (-90.00%) | View |
2022-10-21 4:19 pm Purchase | 13G | Xenetic Biosciences Inc. XBIO | CLS Therapeutics LLC | 1,475,000 9.700% | 1,475,000 (New Position) | View |
2020-12-21 06:20 am Unchanged | 13G | Xenetic Biosciences Inc. XBIO | INTRACOASTAL CAPITAL LLC | 0 0.000% | 0 (Unchanged) | View |
2020-02-14 4:06 pm Sale | 13G | Xenetic Biosciences Inc. XBIO | Anson Funds Management LP | 0 0.000% | -260,000 (Position Closed) | View |
2020-02-13 4:08 pm Sale | 13G | Xenetic Biosciences Inc. XBIO | Altium Capital Management LP | 0 0.000% | -260,000 (Position Closed) | View |
2020-02-10 3:11 pm Sale | 13G | Xenetic Biosciences Inc. XBIO | CVI Investments Inc. | 0 0.000% | -235,000 (Position Closed) | View |
2020-01-21 11:35 am Purchase | 13G | Xenetic Biosciences Inc. XBIO | Empery Asset Management LP | 137,419 2.330% | 137,419 (New Position) | View |
2020-01-13 3:29 pm Purchase | 13G | Xenetic Biosciences Inc. XBIO | SABBY MANAGEMENT LLC | 287,182 11.000% | 33,822 (+13.35%) | View |